Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Armand

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Use of angiogenesis inhibitors in tumour treatmentJérôme Fayette, Jean-Charles Soria, Jean-Pierre Armand
Nature Clinical Practice. Oncology|November 3, 2005
New concepts for phase I trials: evaluating new drugs combined with radiation therapyEric Deutsch, Jean Charles Soria, Jean Pierre Armand
Chinese Clinical Oncology|January 6, 2016
Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitorsSandrine Aspeslagh, Aurélien Marabelle, Jean-Charles Soria, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumorsJean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau, et al.
Annals of Internal Medicine|August 17, 2005
Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?Caroline Robert, Sandrine Faivre, Eric Raymond, et al.
Lancet (London, England)|March 28, 2003
Tyrosine kinase inhibition and grey hairCaroline Robert, Alain Spatz, Sandrine Faivre, et al.
Bulletin Du Cancer|February 7, 2004
[Overview of epidermal growth factor inhibitors (with the exclusion of ZD1839 and C225)]Khémaies Slimane, Jérôme Fayette, Amine Masmoudi, et al.
American Journal of Clinical Oncology|April 7, 2007
QTc monitoring during a phase I study: experience with SR271425Jean-Charles Soria, Veronique Dieras, Veronique Girre, et al.
Cancer Journal (Sudbury, Mass.)|April 15, 2006
Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemiaFrédérique Cvitkovic, Jean-Pierre Armand, Michèle Tubiana-Hulin, et al.
Investigational New Drugs|April 9, 2009
Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumourJulien Domont, Christophe Massard, Nathalie Lassau, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Use of angiogenesis inhibitors in tumour treatmentJérôme Fayette, Jean-Charles Soria, Jean-Pierre Armand
Nature Clinical Practice. Oncology|November 3, 2005
New concepts for phase I trials: evaluating new drugs combined with radiation therapyEric Deutsch, Jean Charles Soria, Jean Pierre Armand
Chinese Clinical Oncology|January 6, 2016
Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitorsSandrine Aspeslagh, Aurélien Marabelle, Jean-Charles Soria, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumorsJean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau, et al.
Annals of Internal Medicine|August 17, 2005
Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?Caroline Robert, Sandrine Faivre, Eric Raymond, et al.
Lancet (London, England)|March 28, 2003
Tyrosine kinase inhibition and grey hairCaroline Robert, Alain Spatz, Sandrine Faivre, et al.
Bulletin Du Cancer|February 7, 2004
[Overview of epidermal growth factor inhibitors (with the exclusion of ZD1839 and C225)]Khémaies Slimane, Jérôme Fayette, Amine Masmoudi, et al.
American Journal of Clinical Oncology|April 7, 2007
QTc monitoring during a phase I study: experience with SR271425Jean-Charles Soria, Veronique Dieras, Veronique Girre, et al.
Cancer Journal (Sudbury, Mass.)|April 15, 2006
Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemiaFrédérique Cvitkovic, Jean-Pierre Armand, Michèle Tubiana-Hulin, et al.
Investigational New Drugs|April 9, 2009
Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumourJulien Domont, Christophe Massard, Nathalie Lassau, et al.
Pageof 6